A series of divalent, monovalent, and zerovalent nickel complexes supported by the electron-releasing, monoanionic tris(phosphino)borate ligands [PhBP3] and [PhBPiPr3] ([PhBP3] = [PhB(CH2PPh2)3]-, [PhBPiPr3] = [PhB(CH2PiPr2)3]-) have been synthesized to explore fundamental aspects of their coordination chemistry. The pseudotetrahedral, divalent halide complexes [PhBP3]NiCl (1), [PhBP3]NiI (2), and [PhBPiPr3]NiCl (3) were prepared by the metalation of [PhBP3]Tl or [PhBPiPr3]Tl with (Ph3P)2NiCl2, NiI2, and (DME)NiCl2 (DME = 1,2-dimethoxyethane), respectively. Complex 1 is a versatile precursor to a series of complexes accessible via substitution reactions including [PhBP3]Ni(N3) (4), [PhBP3]Ni(OSiPh3) (5), [PhBP3]Ni(O-p-tBu-Ph) (6), and [PhBP3]Ni(S-p-tBu-Ph) (7). Complexes 2-5 and 7 have been characterized by X-ray diffraction (XRD) and are pseudotetrahedral monomers in the solid state. Complex 1 reacts readily with oxygen to form the four-electron-oxidation product, [[PhB(CH2POPh2)2(CH2PPh2)]NiCl] (8A or 8B), which features a solid-state structure that is dependent on its method of crystallization. Chemical reduction of 1 using Na/Hg or other potential 1-electron reductants generates a product that arises from partial ligand degradation, [PhBP3]Ni(eta2-CH2PPh2) (9). The more sterically hindered chloride 3 reacts with Li(dbabh) (Hdbabh = 2,3:5,6-dibenzo-7-azabicyclo[2.2.1]hepta-2,5-diene) to provide the three-coordinate complex [kappa2-PhBPiPr3]Ni(dbabh) (11), also characterized by XRD. Chemical reduction of complex 1 in the presence of L-type donors produces the tetrahedral Ni(I) complexes [PhBP3]Ni(PPh3) (12) and [PhBP3]Ni(CNtBu) (13). Reduction of 3 following the addition of PMe3 or tert-butyl isocyanide affords the Ni(I) complexes [PhBPiPr3]Ni(PMe3) (14) and [PhBPiPr3]Ni(CNtBu) (15), respectively. The reactivity of these [PhBP3]NiIL and [PhBPiPr3]NiIL complexes with respect to oxidative group transfer reactions from organic azides and diazoalkanes is discussed. The zerovalent nitrosyl complex [PhBP3]Ni(NO) (16) is prepared by the reaction of 1 with excess NO or by treating 12 with stoichiometric NO. The anionic Ni(0) complexes [[kappa2-PhBP3]Ni(CO)2][nBu4N] (17) and [[kappa2-PhBPiPr3]Ni(CO)2][ASN] (18) (ASN = 5-azoniaspiro[4.4]nonane) have been prepared by reacting [PhBP3]Tl or [PhBPiPr3]Tl with (Ph3P)2Ni(CO)2 in the presence of R4NBr. The photolysis of 17 appears to generate a new species consistent with a zerovalent monocarbonyl complex which we tentatively assign as [[PhBP3]Ni(CO)][nBu4N], although complete characterization of this complex has been difficult. Finally, theoretical DFT calculations are presented for the hypothetical low spin complexes [PhBP3]Ni(NtBu), [PhBPiPr3]Ni(NtBu), [PhBPiPr3]Ni(NMe), and [PhBPiPr3]Ni(N) to consider what role electronic structure factors might play with respect to the relative stability of these species.
No takes yet. Share an insight, caveat, or question.
MacBeth et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: